Related Experiment Video
Updated: Jun 6, 2026
08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
[Innovations in superficial bladder cancer treatments].
Urologia
|November 19, 2010
Summary
Superficial bladder cancer treatment is evolving with new intravesical chemo/immunotherapies. Research focuses on multimodality approaches to improve tumor removal, prevent recurrence, and inhibit progression.
Area of Science:
- Uro-oncology
- Cancer immunology
Context:
- Superficial bladder cancer management presents ongoing challenges for clinicians.
- Current standard treatment involves transurethral resection followed by intravesical chemo/immunotherapy.
Purpose:
- To review recent advancements in superficial bladder cancer therapeutics.
- To highlight emerging multimodality treatment strategies.
Summary:
- The review explores novel therapeutic agents and approaches for superficial bladder cancer.
- Emphasis is placed on treatments combining immunotherapeutic and chemotherapeutic modalities.
- Investigational therapies show promising outcomes in preclinical and clinical settings.
Impact:
- These advancements aim to optimize tumor eradication, reduce recurrence rates, and prevent disease progression.
- The integration of novel strategies offers potential for improved patient outcomes in bladder cancer care.
